International Journal of Pharmacology and Clinical Sciences,2018,7,4,2-3.DOI:10.5530/ijpcs.2018.7.2Published:November 2018Type:Review ArticleAuthors:Yousef Ahmed Alomi, Nora Alsolami, Nada Alqahtani, Dalal Alqahtani, and Saeed Alqahtani Author(s) affiliations:Yousef Ahmed Alomi1,* , Nora Alsolami2, Nada Alqahtani3, Dalal Alqahtani4, Saeed Alqahtani5 1The Past General Manager of General Administration of Pharmaceutical Care Head, National Clinical Pharmacy and Pharmacy Practice Programs, Head, Pharmacy R and D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. 2Head, Pharmaceutical Care Services, Al-Amel Medical Complex, Ministry of Health, Riyadh, Riyadh, SAUDI ARABIA. 3Head, Drug Information Services, Al-Amel Medical Complex, Ministry of Health, Riyadh, SAUDI ARABIA. 4Clinical Pharmacy Staff, Al-Amel Medical Complex, Ministry of Health, Riyadh, SAUDI ARABIA. Abstract:The general administration of pharmaceutical care at the Ministry of Health in Saudi Arabia has released several pharmacy practice programs. The national pharmacy psychiatric program was one among them. This program has been established for the psychiatric management with an emphasis on schizophrenia. The guidelines inthis program have been implemented in the form of a physician order form. This form consists of the best therapeutic choice for the conventional type of schizophrenia, or schizophrenia with comorbid disease. The schizophrenia guidelines have been approved by the medical staff and have been implemented at the hospital. This type of management of schizophrenia will prevent drug-related problems and improve clinical outcome of the patients. It is the first new initiative project at the Ministry of Health and in the Middle Eastern countries. Keywords:Ministry of Health, Physician Oder, Saudi Arabia, Schizophrenia treatmentView:PDF (256.38 KB) PDFClick here to download the PDF file. Images International Journal of Pharmacy and Health Sciences